Biotech Startups

Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.

1 investor

Medical Excellence Capital is a venture capital firm investing in early-stage life science and healthcare companies. The fund focuses on biotech, therapeutics, diagnostics, and medical device innovations, and is founded by and operates for patient benefit in the healthcare sector.

1 investor

Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products. It operates a fully integrated North American business model spanning commercial operations, supply chain, regulatory, medical affairs, and sales.

1 investor

Medipost is a biotechnology company focused on stem cell technology, including stem cell banking services and related research and development. It holds domestic and international patents and conducts government-funded research projects.

1 investor

Medibiofarma develops novel therapeutic treatments, including assets advancing into areas such as women's health and oncology. The company is associated with the launch of Oriva Therapeutics and licensing of assets originating from Oncostellae.

1 investor

MNS (Microneedle Solutions) develops medical technology based on microneedle systems, with stated aims of reducing health disparities and improving access to quality healthcare. The company originated from university research and works with advisors in RNA technologies and vaccines.

1 investor

Medicinal Genomics provides microbial and plant testing solutions for the cannabis, nutraceutical, and food safety industries through validated qPCR assays and automated liquid handling platforms. Their offerings enable rapid pathogen detection and species identification with turnaround times measured in hours rather than days.

1 investor

MediciNova is a biopharmaceutical company that develops new drugs for diseases with limited or unestablished treatment options, aiming to serve patients with unmet medical needs. It focuses on discovering safe and effective medicines through drug discovery technology and collaborations with research institutions, medical institutions, and companies.

1 investor

Medicus AI develops an AI-powered healthcare platform that analyzes cell-level spatial biomarker data and converts it into quantitative indicators for precision cancer diagnosis and treatment. It provides AI diagnostic support and connects hospitals and pharmaceutical companies to aid drug development and precision medicine research.

1 investor

MediSieve develops a magnetic blood filtration system that uses nanoengineered magnetic particles and beads to remove pathogens such as harmful cells, bacteria, toxins, and inflammatory cytokines directly from a patient's bloodstream. The technology targets treatment for currently underserved patient groups.

1 investor

Medisix Therapeutics develops a pipeline of therapeutic products using integrated technology platforms spanning the product lifecycle, supported by a CMC platform for large-scale manufacturing.

1 investor

MediTrak provides a hypertension management solution for patients and healthcare providers. The company operates in the digital health space.

1 investor

BioResin develops bio-separation technology that upcycles agricultural byproducts such as acid whey, pea, and soy waste streams into edible "magnetic" fibers used to capture and purify proteins. Its products serve food and alternative-protein producers, including precision fermentation and plant-based applications, offering both a dual-upcycled fiber-protein hybrid ingredient and a food-grade high-purity processing aid.

1 investor

Medivant Healthcare manufactures sterile injectable medications for the pharmaceutical industry.

1 investor

Mednet provides a unified electronic clinical trial platform that enables sponsors, contract research organizations, and life sciences research organizations to design, build, and manage clinical studies. The company serves pharmaceutical, biotechnology, medical device, and academic institutions with eClinical technology and operational expertise across North America and globally.

1 investor

MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.

1 investor

MedTech Innovator runs accelerator programs for medical device, diagnostics, and life science tools startups, providing non-dilutive funding, mentorship, and an ecosystem of over 700 companies. It operates initiatives including MedTech Innovator Vantage (the diagnostics and medical devices hub of the BARDA Accelerator Network) and BioTools Innovator to advance healthcare and public health emergency readiness in the United States.

1 investor

Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications. The company operates through collaborative research partnerships with academic institutions and pharmaceutical manufacturers in Japan and internationally.

1 investor

Melior Discovery provides in vivo pharmacology services and phenotypic screening platforms for pharmaceutical and biopharmaceutical companies to evaluate candidate therapeutics in animal disease models. The company operates proprietary technology including theraTRACE® to identify new therapeutic potential and support drug development and repositioning.

1 investor

Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.

1 investor

Melius Pharma is a drug development company that operates with part-time experts and external providers to conduct strategic and operational pharmaceutical development. The company focuses on formulation development and clinical advancement in the pharmaceutical sector.

1 investor

Mensura Health is developing an electrochemical point-of-care diagnostic system that uses DNA aptamer-based sensors and disposable microfluidic cartridges to rapidly measure blood levels of anti-seizure medications in epilepsy patients. The technology is intended to help clinicians perform therapeutic drug monitoring and optimize drug dosing during office visits and other care settings.

1 investor

Mentari Therapeutics develops targeted biological therapies for migraine treatment, focusing on PACAP pathway inhibition through monoclonal and bispecific antibodies for patients with inadequate relief from existing anti-CGRP therapies.

1 investor

MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.

1 investor